Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Novo Nordisk Is Already Working on Ozempic 2.0
Motley Fool
Thu, 09/7/23 - 10:12 am
Novo Nordisk
diabetes
obesity
weight loss
Ozempic
Wegovy
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company
FT.com
Tue, 09/5/23 - 11:38 am
Novo Nordisk
Wegovy
Europe
weight loss
Novo Nordisk launches Wegovy for obese patients in UK
Pharmaceutical Business Review
Tue, 09/5/23 - 11:25 am
Novo Nordisk
UK
Wegovy
obesity
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs
Clinical Trials Arena
Fri, 09/1/23 - 12:18 pm
Novo Nordisk
Wegovy
Ozempic
Denmark
Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death
Airfinity
Thu, 08/31/23 - 11:52 am
Novo Nordisk
Wegovy
Ozempic
cardiovascular disease
Are weight loss drugs a win for the global economy?
Pharma Voice
Thu, 08/31/23 - 10:14 am
Novo Nordisk
Wegovy
weight loss
Ozempic
US senators push drugmakers for details on low-cost insulin programs
Yahoo/Reuters
Thu, 08/31/23 - 10:11 am
Senate
insulin
drug pricing
Novo Nordisk
Eli Lilly
Sanofi
diabetes
Novo Bolsters Obesity Pipeline with Potential $500M Embark Biotech Buy
BioSpace
Wed, 08/30/23 - 11:22 am
Novo Nordisk
Embark Biotech
obesity
M&A
Shares of Wegovy Partner Catalent Jump After Striking Deal With Activist Investor Elliott
Investopedia
Wed, 08/30/23 - 10:03 am
Catalent
Wegovy
Novo Nordisk
Elliott Management
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
Why Wegovy's Sales Potential Could Be Massively Understated
Motley Fool
Tue, 08/29/23 - 11:08 am
Novo Nordisk
Wegovy
heart attack
stroke
Novo Nordisk set to launch weight loss drugs in more countries but in constrained fashion, CEO says
Fierce Pharma
Mon, 08/28/23 - 08:00 pm
Novo Nordisk
weight loss
Wegovy
Ozempic
On a roll, Novo's star obesity drug Wegovy shows benefits in patients with heart failure
Fierce Pharma
Fri, 08/25/23 - 11:54 am
Novo Nordisk
Wegovy
heart failure
clinical trials
Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO Says
Forbes
Fri, 08/25/23 - 09:48 am
Novo Nordisk
Wegovy
Lars Fruergaard Jorgensen
weight loss
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
Motley Fool
Thu, 08/24/23 - 09:50 pm
Novo Nordisk
Ozempic
diabetes
weight loss
liver disease
addiction
cardiovascular disease
Novo Nordisk enlists Thermo Fisher as second Wegovy manufacturer: report
Medical Marketing and Media
Wed, 08/23/23 - 05:38 pm
Novo Nordisk
Thermo Fisher
drug manufacturing
Wegovy
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Yahoo/Zacks.com
Tue, 08/22/23 - 09:58 am
earnings
Eli Lilly
JNJ
Novo Nordisk
Novartis
AstraZeneca
Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print
Forbes
Mon, 08/21/23 - 10:38 am
weight loss
Novo Nordisk
Wegovy
Ozempic
Demand for weight loss drugs soars to nearly half of Americans
Pharma Voice
Wed, 08/16/23 - 10:14 am
weight loss
Novo Nordisk
Ozempic
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
…
next ›
last »